NEW YORK / Oct 11, 2023 / Business Wire / DocGo Inc. (Nasdaq:DCGO), a leading provider of technology-enabled mobile health services, is proud to be Certified™ by Great Place To Work®. The prestigious award is based entirely on what current employees say about their experience working at DocGo. This is the company’s second time participating in the certification process, and the second time it earned the prized certification.
Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver growth, employee retention and increased innovation.
“We are humbled by this achievement,” said Lee Bienstock, CEO of DocGo. “This recognition reflects our commitment to elevating our employee experience in an inclusive, collaborative, and purpose-driven environment. Our success is rooted in the dedication of our incredible team and the immense talent they bring to our shared mission. We thank our team for continuing to make DocGo a great place to work, and they have our commitment to continue to help them flourish in their careers at DocGo, and to celebrate them every step of the way.”
"Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience," says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work. She emphasizes that certification is the sole official recognition earned by the real-time feedback of employees regarding their company culture. “By successfully earning this recognition, it is evident that DocGo stands out as one of the top companies to work for, providing a great workplace environment for its employees."
DocGo is committed to its employees' success and career development. Its healthcare providers are trained to bring care to patients where and when it is needed, outside of traditional healthcare settings. DocGo provides field staff the clinical training they need to build their skills and advance their careers. DocGo provides leadership training to management staff as well as other programs, educational opportunities, and an Employee Equity Incentive Plan that enables select employees to earn an ownership stake in the company. DocGo believes that engaged, satisfied employees go the extra mile to deliver high quality care and an improved patient experience. DocGo is rated a 4.3/5 on Indeed and a 4.0/5 on Glassdoor – ratings that far exceed other healthcare providers. This award is a further demonstration that happy team members make for happy patients.
According to Great Place to Work research, job seekers are 4.5 times more likely to find a great boss at a certified great workplace. Additionally, employees at Certified workplaces are 93 percent more likely to look forward to coming to work and are twice as likely to be paid fairly, earn a fair share of the company's profits and have a fair chance at promotion.
About DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo disrupts the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo's proprietary, AI-powered technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With mobile health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit docgo.com.
Last Trade: | US$4.23 |
Daily Change: | -0.06 -1.40 |
Daily Volume: | 84,929 |
Market Cap: | US$431.670M |
November 26, 2024 November 07, 2024 October 09, 2024 September 19, 2024 August 07, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB